New resins enable solid-phase synthesis of peptide N-alkylamides. This method efficiently produces Gonadotropin-releasing hormone (GnRH) analogs, with one analog showing threefold increased potency in releasing luteinizing hormone (LH).
Area of Science:
Organic Chemistry
Peptide Chemistry
Medicinal Chemistry
Background:
Solid-phase peptide synthesis (SPPS) is a cornerstone of peptide production.
Developing efficient methods for synthesizing modified peptides, such as C-terminal peptide N-alkylamides, remains an active area of research.
Gonadotropin-releasing hormone (GnRH) analogs are crucial for reproductive medicine and endocrinology.
Purpose of the Study:
To develop novel resins for the solid-phase synthesis of C-terminal peptide N-alkylamides.
To demonstrate the utility of these resins in synthesizing GnRH analogs.
To evaluate the biological activity of newly synthesized GnRH analogs.
Main Methods:
Preparation of three new polystyrene-based resins functionalized with different alkylamines.
Solid-phase synthesis of C-terminal peptide N-alkylamides using Boc amino acids and standard protecting groups.
Cleavage and deprotection using hydrogen fluoride (HF).
Synthesis and characterization of GnRH analogs, including [DGlu6, Pro9-NHCH2CH3]-GnRH.
In vitro testing of GnRH analogs for luteinizing hormone (LH) release from rat anterior pituitary cells.
Main Results:
The developed resins successfully facilitated the solid-phase synthesis of C-terminal peptide N-alkylamides.
A novel analog, [DGlu6, Pro9-NHCH2CH3]-GnRH, was synthesized and found to be three times more potent than [DGlu6]-GnRH in stimulating LH release.
Other synthesized GnRH analogs exhibited equipotency and comparable properties (HPLC, amino acid analysis, specific rotation) to those obtained via alternative methods.
Equivalent or improved yields were achieved compared to previous synthetic strategies.
Conclusions:
The newly developed resins offer a versatile and efficient approach for the solid-phase synthesis of C-terminal peptide N-alkylamides.
This methodology enables the streamlined production of potent GnRH analogs with potential therapeutic applications.
The findings highlight the significance of C-terminal modifications in modulating peptide hormone activity.